Abstract
BackgroundThe gp85 is the main envelope protein of avian leukosis subgroup J (ALV-J) involved in virus neutralization. Here, we mapped the epitope in ALV-J gp85 by ELISA using synthetic peptides and developed epitope based diagnostic methods for ALV-J infection.ResultsThe results revealed that monoclonal antibody (mAb) JE9 recognized 83WDPQEL88 motif, which was highly conserved in gp85 among different ALV-J strains by homology analysis. Moreover, after evaluation with two hundred and forty sera samples obtained from different chicken farms, the epitope-based peptide ELISA had much higher sensitivity than commercial ELISA kit for antibody detection of ALV-J.ConclusionsA novel B-cell epitope recognized by the mAb JE9 was identified. The developed peptide-ELISA based on this novel B-cell epitope could be useful in laboratory viral diagnosis, routine surveillance in chicken farms, and also in understanding the pathogenesis of ALV-J.
Highlights
The gp85 is the main envelope protein of avian leukosis subgroup J (ALV-J) involved in virus neutralization
We identified a conserved linear B-cell epitope recognised by the monoclonal antibody (mAb) JE9 using synthetic peptides, and applied it for the diagnosis of avian leukosis virus subgroup J (ALV-J) infection using an epitope-based peptide Enzyme-linked immunosorbent assay (ELISA)
We identified WDPQEL as the target sequence of mAb JE9, which corresponds to 83–88 aa of ALV-gp85 as deletion of 83 W or 88 L disrupted the binding of the peptides with mAb JE9
Summary
The gp is the main envelope protein of avian leukosis subgroup J (ALV-J) involved in virus neutralization. We mapped the epitope in ALV-J gp by ELISA using synthetic peptides and developed epitope based diagnostic methods for ALV-J infection. Since the first report of avian leukosis virus subgroup J (ALV-J) in the United Kingdom in 1988, the virus has spread rapidly to many countries including China [1,2,3,4,5]. We showed that the gp85-specific mAb JE9 could react with different ALV-J strains but not with other ALV subgroups [13], confirming that the mAb JE9 recognized a conserved antigenic epitope. We identified a conserved linear B-cell epitope recognised by the mAb JE9 using synthetic peptides, and applied it for the diagnosis of ALV-J infection using an epitope-based peptide ELISA. The results in this study will contribute to the understanding of the antigenic structure of gp and rational design of vaccines and diagnostic tools
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.